Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 36

2.

Role of hyaluronan-mediated CD44 signaling in head and neck squamous cell carcinoma progression and chemoresistance.

Wang SJ, Bourguignon LY.

Am J Pathol. 2011 Mar;178(3):956-63. doi: 10.1016/j.ajpath.2010.11.077. Review.

3.

The role of CD44 in the development and prognosis of head and neck squamous cell carcinomas.

Assimakopoulos D, Kolettas E, Patrikakos G, Evangelou A.

Histol Histopathol. 2002 Oct;17(4):1269-81. Review.

PMID:
12371152
4.

Expression of c-erbB receptors, MMPs and VEGF in head and neck squamous cell carcinoma.

Lim SC.

Biomed Pharmacother. 2005 Oct;59 Suppl 2:S366-9. Review.

PMID:
16507411
5.

Molecular markers of metastasis in squamous carcinomas.

Helliwell TR.

J Pathol. 2001 Jul;194(3):289-93. Review.

PMID:
11439359
6.

CD44 isoform-cytoskeleton interaction in oncogenic signaling and tumor progression.

Bourguignon LY, Zhu D, Zhu H.

Front Biosci. 1998 Jul 1;3:d637-49. Review.

PMID:
9634539
7.

Role of metalloproteins in the clinical management of head and neck squamous cell carcinoma.

Scurry WC Jr, Stack BC Jr.

Head Neck. 2007 Dec;29(12):1144-55. Review.

PMID:
17657798
8.

CD44 family and gynaecological cancer.

Makrydimas G, Zagorianakou N, Zagorianakou P, Agnantis NJ.

In Vivo. 2003 Nov-Dec;17(6):633-40. Review.

PMID:
14758731
9.

Can biomarkers play a role in the decision about treatment of the clinically negative neck in patients with head and neck cancer?

Takes RP, Rinaldo A, Rodrigo JP, Devaney KO, Fagan JJ, Ferlito A.

Head Neck. 2008 Apr;30(4):525-38. doi: 10.1002/hed.20759. Review.

PMID:
18213721
10.

Head and neck squamous cell carcinoma cell lines: established models and rationale for selection.

Lin CJ, Grandis JR, Carey TE, Gollin SM, Whiteside TL, Koch WM, Ferris RL, Lai SY.

Head Neck. 2007 Feb;29(2):163-88. Review.

PMID:
17312569
11.

CD44 expression is predictive of poor prognosis in pharyngolaryngeal cancer: systematic review and meta-analysis.

Chai L, Liu H, Zhang Z, Wang F, Wang Q, Zhou S, Wang S.

Tohoku J Exp Med. 2014;232(1):9-19. Review.

12.

Significance of CD44 expression in head and neck cancer: a systemic review and meta-analysis.

Chen J, Zhou J, Lu J, Xiong H, Shi X, Gong L.

BMC Cancer. 2014 Jan 13;14:15. doi: 10.1186/1471-2407-14-15. Review.

13.

Molecular mediators of metastasis in head and neck squamous cell carcinoma.

Howell GM, Grandis JR.

Head Neck. 2005 Aug;27(8):710-7. Review.

PMID:
15952195
14.

Molecular studies into the role of CD44 variants in metastasis in gastric cancer.

Hsieh HF, Yu JC, Ho LI, Chiu SC, Harn HJ.

Mol Pathol. 1999 Feb;52(1):25-8. Review.

16.

The role of matrix extracellular proteins and metalloproteinases in head and neck carcinomas: an updated review.

Pereira AL, Veras SS, Silveira EJ, Seabra FR, Pinto LP, Souza LB, Freitas RA.

Braz J Otorhinolaryngol. 2005 Jan-Feb;71(1):81-6. Epub 2006 Jan 2. Review.

17.

Role and expression patterns of E-cadherin in head and neck squamous cell carcinoma (HNSCC).

Georgolios A, Batistatou A, Manolopoulos L, Charalabopoulos K.

J Exp Clin Cancer Res. 2006 Mar;25(1):5-14. Review.

PMID:
16761612
18.

The normal structure and function of CD44 and its role in neoplasia.

Sneath RJ, Mangham DC.

Mol Pathol. 1998 Aug;51(4):191-200. Review.

19.

CD44, a therapeutic target for metastasising tumours.

Orian-Rousseau V.

Eur J Cancer. 2010 May;46(7):1271-7. doi: 10.1016/j.ejca.2010.02.024. Epub 2010 Mar 19. Review.

PMID:
20303742
20.

Integrins in head and neck squamous cell carcinoma (HNSCC): a review of the current literature.

Georgolios AK, Batistatou A, Charalabopoulos K.

Cell Commun Adhes. 2005 Jan-Apr;12(1-2):1-8. Review.

PMID:
16371342
Items per page

Supplemental Content

Write to the Help Desk